Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 45.85B | 75.01B | 73.58B | 70.27B | 60.10B | 58.54B |
Gross Profit | 21.11B | 34.38B | 32.83B | 32.07B | 28.57B | 28.36B |
EBITDA | 9.33B | 15.80B | 15.02B | 13.96B | 15.33B | 14.29B |
Net Income | 3.56B | 9.12B | -40.79B | -1.06B | 6.85B | 6.03B |
Balance Sheet | ||||||
Total Assets | 154.62B | 113.33B | 111.83B | 115.34B | 126.38B | 118.82B |
Cash, Cash Equivalents and Short-Term Investments | 10.10B | 11.60B | 15.62B | 8.16B | 8.34B | 8.09B |
Total Debt | 74.08B | 38.14B | 39.10B | 28.65B | 28.92B | 30.25B |
Total Liabilities | 126.85B | 82.72B | 86.08B | 80.62B | 77.63B | 75.45B |
Stockholders Equity | 25.02B | 27.77B | 23.23B | 31.90B | 45.50B | 39.31B |
Cash Flow | ||||||
Free Cash Flow | 2.79B | 6.28B | 7.36B | 8.93B | 9.04B | 6.53B |
Operating Cash Flow | 5.31B | 11.31B | 11.61B | 12.95B | 13.26B | 10.93B |
Investing Cash Flow | -32.01B | -1.52B | -6.73B | -3.06B | -4.38B | -5.87B |
Financing Cash Flow | 24.61B | -13.94B | 1.37B | -9.76B | -8.95B | -1.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $34.87B | 13.30 | 15.08% | 2.10% | -0.79% | -10.83% | |
75 Outperform | $2.17B | 13.70 | 10.15% | 3.88% | 13.92% | 32.69% | |
74 Outperform | $116.32B | 16.54 | 8.97% | 1.76% | -2.06% | 21.03% | |
71 Outperform | $16.11B | 15.62 | 27.63% | 3.37% | 10.69% | ― | |
66 Neutral | $9.06B | 9.14 | 7.79% | 4.05% | -5.48% | -6.99% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | $24.45B | 49.10 | -5.05% | 2.90% | -0.47% | -117.62% |